Charles Schwab’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-224
| Closed | -$67.1K | – | 3649 |
|
|
2024
Q1 | $67.1K | Hold |
224
| – | – | ﹤0.01% | 3341 |
|
|
2023
Q4 | $52.8K | Hold |
224
| – | – | ﹤0.01% | 3399 |
|
|
2023
Q3 | $33.5K | Hold |
224
| – | – | ﹤0.01% | 3449 |
|
|
2023
Q2 | $38.9K | Hold |
224
| – | – | ﹤0.01% | 3454 |
|
|
2023
Q1 | $28.2K | Hold |
224
| – | – | ﹤0.01% | 3458 |
|
|
2022
Q4 | $67.8K | Buy |
+224
| New | +$67.8K | ﹤0.01% | 3304 |
|
|
2022
Q3 | – | Sell |
-604
| Closed | -$37K | – | 3524 |
|
|
2022
Q2 | $37K | Buy |
+604
| New | +$37K | ﹤0.01% | 3433 |
|
|
2022
Q1 | – | Sell |
-349
| Closed | -$51K | – | 3597 |
|
|
2021
Q4 | $51K | Hold |
349
| – | – | ﹤0.01% | 3513 |
|
|
2021
Q3 | $77K | Buy |
349
+235
| +206% | +$51.8K | ﹤0.01% | 3407 |
|
|
2021
Q2 | $27K | Sell |
114
-763
| -87% | -$181K | ﹤0.01% | 3407 |
|
|
2021
Q1 | $264K | Hold |
877
| – | – | ﹤0.01% | 3274 |
|
|
2020
Q4 | $330K | Hold |
877
| – | – | ﹤0.01% | 3119 |
|
|
2020
Q3 | $270K | Sell |
877
-5
| -0.6% | -$1.54K | ﹤0.01% | 3063 |
|
|
2020
Q2 | $332K | Buy |
882
+64
| +8% | +$24.1K | ﹤0.01% | 2995 |
|
|
2020
Q1 | $187K | Hold |
818
| – | – | ﹤0.01% | 3025 |
|
|
2019
Q4 | $433K | Hold |
818
| – | – | ﹤0.01% | 2877 |
|
|
2019
Q3 | $353K | Hold |
818
| – | – | ﹤0.01% | 2925 |
|
|
2019
Q2 | $975K | Buy |
818
+32
| +4% | +$38.1K | ﹤0.01% | 2583 |
|
|
2019
Q1 | $980K | Buy |
786
+22
| +3% | +$27.4K | ﹤0.01% | 2557 |
|
|
2018
Q4 | $724K | Hold |
764
| – | – | ﹤0.01% | 2636 |
|
|
2018
Q3 | $1.1M | Buy |
764
+24
| +3% | +$34.6K | ﹤0.01% | 2591 |
|
|
2018
Q2 | $1.19M | Buy |
+740
| New | +$1.19M | ﹤0.01% | 2534 |
|
|
2017
Q2 | – | Sell |
-196
| Closed | -$107K | – | 3114 |
|
|
2017
Q1 | $107K | Hold |
196
| – | – | ﹤0.01% | 3008 |
|
|
2016
Q4 | $120K | Hold |
196
| – | – | ﹤0.01% | 3030 |
|
|
2016
Q3 | $141K | Hold |
196
| – | – | ﹤0.01% | 2980 |
|
|
2016
Q2 | $143K | Buy |
+196
| New | +$143K | ﹤0.01% | 3015 |
|